Tessera Therapeutics amasses $230m: TechCrunch

Tessera Therapeutics, a provider of programmable genetics, has raised $230 million in funding, reported TechCrunch.

Tessera Therapeutics, a provider of programmable genetics, has raised $230 million in funding, reported TechCrunch. Alaska Permanent Fund Corp., Altitude Life Science Ventures and the second SoftBank Vision Fund led the round.

Source: TechCrunch